当前位置: X-MOL 学术Stem Cell Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Whole body deletion of Gpr68 does not change hematopoietic stem cell function.
Stem Cell Research ( IF 1.2 ) Pub Date : 2020-06-20 , DOI: 10.1016/j.scr.2020.101869
Xiaofei He 1 , Caleb Hawkins 1 , Lauren Lawley 1 , Kennedy Freeman 1 , Tra Mi Phan 1 , Jiajia Zhang 2 , Yan Xu 3 , Jing Fang 1
Affiliation  

G protein-coupled receptor 68 (GPR68) responds to extracellular protons, thus called the proton-sensing G protein-coupled receptor (GPCR), leading to activation of the phospholipase C-β (PLCβ)/calcium (Ca2+) pathway or the adenylyl cyclase (AC)/cyclic AMP (cAMP) pathway. We recently found that whole body deletion of Gpr68 (Gpr68−/− mice) reduced the number of B lymphocytes with age and during hematopoietic regeneration, such as in response to fluorouracil (5-FU) administration. This prompted us to characterize the hematopoietic stem cell (HSC) phenotype in Gpr68−/− mice. Despite high level of Gpr68 protein expression on HSC in bone marrow (BM), the pool size of HSC was unaltered in Gpr68−/− mice either under steady state or upon stress, including aging and 5-FU treatment. HSC from Gpr68−/− mice exhibited comparable cellular features, such as cell cycle quiescence and cell survival. HSC from Gpr68−/− mice also exhibited comparable competitiveness after serial transplantation. Surprisingly, cytosolic Ca2+ accumulation was increased in HSC from Gpr68−/− mice. In contrast, cAMP levels were reduced in hematopoietic stem and progenitor cells (HSPC) from Gpr68−/− mice. Intriguingly, we found high level of Gpr68 protein expression on non-hematopoietic cells in BM, especially endothelial cells that function as HSC niche. In addition, expression of other proton-sensing GPCR was upregulated in HSPC from Gpr68−/− mice. Our studies suggest that Gpr68−/− mice display insignificant phenotype on HSC biology, possibly due to the function of Gpr68 in non-hematopoietic cells and/or the compensatory effects from other proton-sensing GPCR.



中文翻译:

Gpr68 的全身缺失不会改变造血干细胞功能。

G 蛋白偶联受体 68 (GPR68) 响应细胞外质子,因此称为质子感应 G 蛋白偶联受体 (GPCR),导致磷脂酶 C-β (PLCβ)/钙 (Ca 2+ ) 通路的激活或腺苷酸环化酶 (AC)/环 AMP (cAMP) 途径。我们最近发现 Gpr68 的全身缺失(Gpr68 -/-小鼠)会随着年龄和造血再生过程中的 B 淋巴细胞数量减少,例如对氟尿嘧啶 (5-FU) 给药的反应。这促使我们表征 Gpr68 -/-小鼠中的造血干细胞 (HSC) 表型。尽管骨髓 (BM) 中 HSC 上的 Gpr68 蛋白表达水平高,但 Gpr68 中 HSC 的池大小未改变-/-小鼠处于稳态或处于应激状态,包括衰老和 5-FU 治疗。来自 Gpr68 -/-小鼠的HSC表现出类似的细胞特征,例如细胞周期静止和细胞存活。来自 Gpr68 -/-小鼠的HSC在连续移植后也表现出相当的竞争力。令人惊讶的是,来自 Gpr68 -/-小鼠的HSC 中的胞质 Ca 2+积累增加。相反,来自 Gpr68 -/- 的造血干细胞和祖细胞 (HSPC) 中的 cAMP 水平降低老鼠。有趣的是,我们在 BM 的非造血细胞上发现了高水平的 Gpr68 蛋白表达,尤其是作为 HSC 生态位的内皮细胞。此外,其他质子感应 GPCR 的表达在来自 Gpr68 -/-小鼠的HSPC 中上调。我们的研究表明 Gpr68 -/-小鼠在 HSC 生物学上表现出微不足道的表型,这可能是由于 Gpr68 在非造血细胞中的功能和/或其他质子感应 GPCR 的代偿作用。

更新日期:2020-06-20
down
wechat
bug